<SEC-DOCUMENT>0000919574-21-000006-index.html : 20210104
<SEC-HEADER>0000919574-21-000006.hdr.sgml : 20210104
<ACCEPTANCE-DATETIME>20210104111527
ACCESSION NUMBER:		0000919574-21-000006
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210104
DATE AS OF CHANGE:		20210104
GROUP MEMBERS:		BROADFIN CAPITAL, LLC
GROUP MEMBERS:		BROADFIN HEALTHCARE MASTER FUND, LTD.
GROUP MEMBERS:		KEVIN KOTLER

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-44849
		FILM NUMBER:		21500623

	BUSINESS ADDRESS:	
		STREET 1:		4747 EXECUTIVE DRIVE, SUITE 240
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4747 EXECUTIVE DRIVE, SUITE 240
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Broadfin Capital, LLC
		CENTRAL INDEX KEY:			0001511901
		IRS NUMBER:				202924429
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		300 PARK AVENUE, 25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-808-2460

	MAIL ADDRESS:	
		STREET 1:		300 PARK AVENUE, 25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>d8591586_13g-a.htm
<TEXT>
Document 1 - file: d8591586_13g-a.htm

</DOCUMENT>
</SEC-DOCUMENT>